Background
Methods
Information sources and search strategy
Study selection and inclusion criteria
Data extraction
Results
Australia | New Zealand | USA | Canada | Total | |
---|---|---|---|---|---|
Publication type | |||||
Journal article | 8 | 2 | 7 | 3 | 20 |
Conference abstract | 0 | 3 | 2 | 0 | 5 |
Report | 1 | 1 | 0 | 0 | 2 |
Study design | |||||
Cohort | 1 | 1 | 2 | 1 | 5 |
Case–control | 0 | 0 | 0 | 0 | 0 |
Cross-sectional | 4 | 0 | 5 | 0 | 9 |
Descriptive | 4 | 5 | 2 | 2 | 13 |
Epidemiological index or themea | |||||
Antecedents of AF | 0 | 0 | 2 | 0 | 2 |
Incidence of AF in a population | 1 | 0 | 0 | 1 | 2 |
Prevalence of AF in a population | 1 | 2 | 1 | 1 | 5 |
AF in primary care consultations | 1 | 0 | 0 | 0 | 1 |
AF hospital admission rates | 0 | 1 | 0 | 0 | 1 |
Outcomes in AF patients | 1 | 1 | 1 | 1 | 4 |
Health service provision | 0 | 0 | 0 | 1 | 1 |
AF as an outcome | 0 | 0 | 1 | 0 | 1 |
Occurrence of AF in a clinical group | 6 | 2 | 4 | 2 | 14 |
Primary focus on AF | |||||
Yes—Indigenous AF | 3 | 2 | 3 | 1 | 9 |
Yes—AF (Other) | 0 | 1 | 3 | 0 | 4 |
No | 6 | 3 | 3 | 2 | 14 |
Setting | |||||
Community | 1 | 2 | 4 | 0 | 7 |
Primary care | 1 | 0 | 0 | 0 | 1 |
Hospital patients: no population denominator | 4 | 3 | 4 | 1 | 12 |
Hospital patients: population denominator | 3 | 1 | 0 | 2 | 6 |
Hospital patients and community | 0 | 0 | 1 | 0 | 1 |
Calendar period of final data collection | |||||
1980-1995 | 0 | 1 | 0 | 0 | 1 |
1996-2005 | 0 | 2 | 3 | 0 | 5 |
2006 onwards | 9 | 3 | 6 | 3 | 21 |
Total | 9 | 6 | 10 | 3 | 27 |
Antecedents of AF
Author (Year) Publication type | Country Indigenous population Calendar period | Methods | Key findings on Indigenous AF | Quality score (Newcastle-Ottawa Scale applied only to Indigenous AF data) Comments |
---|---|---|---|---|
Antecedents of AF | ||||
Title: Association of Markers of Inflammation with New-Onset Atrial Fibrillation in a Population-Based Sample: The Strong Heart Study
| ||||
Zacks (2006) [32] Conference abstract | Country: US | Design: Population-based cohort study | New-onset AF (n = 100 participants) independently predicted by serum CRP level (HR 1.44 per mg/L [95 % CI 1.17–1.77], p = 0.001), and by fibrinogen level (HR 1.31 per 83.44 mg/dL [=1 SD of mean][95 % CI 1.06–1.61], p = 0.013) | NOS: N/A (abstract) No non-American Indian comparison group; data presented as generalisable evidence that CRP & fibrinogen are additive risk factors for new-onset AF (independent of effects of gender, age, hypertension, BMI, and urinary albumin-creatinine ratio) |
Population: American Indians | Data Source: Strong Heart | |||
Period: enrolled 1993–1995 with 10 years follow-up | Study: prospectively collected population-based survey of risk factors | |||
Sample size: 3541 | Setting: 13 American Indian communities | |||
Sample size: 3541 | ||||
Title: Association of Left Ventricular Mass and Ejection Fraction with New-Onset Atrial Fibrillation in a Population-Based Sample: The Strong Heart Study
| ||||
Zacks (2006) [33] Conference abstract | Country: US | Design: Population-based cohort study | New-onset AF (n = 91 participants) independently predicted by increased LV mass indexed for height (HR 1.49 per 11 gm/m2.7 [=1 SD of mean][95 % CI 1.24–1.78], p ≤ 0.0001), and (n = 88) by reduced LVEF (HR 0.65 per 14 % [=1 SD of mean][95 % CI 0.52–0.82], p ≤ 0.0001) | NOS: N/A (abstract) No non-American Indian comparison group; data presented as generalisable evidence that LV mass index and LVEF are additive risk factors for new-onset AF (independent of effects of gender, age, hypertension, BMI, urinary albumin-creatinine ratio, CRP and fibrinogen) |
Population: American Indians | Data Source: Strong Heart | |||
Period: enrolled 1993–1995 with 10 years follow-up | Study: prospectively collected population-based survey of risk factors | |||
Sample size: 3541 | Setting: 13 American Indian communities | |||
Sample size: 3541 | ||||
Incidence in population | ||||
Title: Cardiovascular Disease Rates, Outcomes, and Quality of Care in Ontario Métis: A Population-Based Cohort Study
| ||||
Atzema (2015) [31] Journal article (this study has multiple outcomes) | Country: Canada (Ontario only) | Design: Retrospective cohort study (18 % of Métis population) | Age- & sex-adjusted incidence per 100 (CI): Métis0.62 (0.50–0.73) | NOS (cohort): 7/9 Incidence well-defined. Register not representative; Out-of-hospital cases not included; very small numbers of incident cases |
Population: Métis | Data Source: Ontario Métis register linked to emergency department (ED), in-patient hospital & mortality records | All Ontario 0.32 (0.32–0.32) | ||
Period: 2006-2011 | Setting: ED and hospital based cases | p < 0.001 | ||
Age: 20 years & over | Other: 5-year clearance period | |||
Sample size: 56 cases of 12,550 (7 % of provincial Métis population) | ||||
Title: Initial hospitalisation for atrial fibrillation in Aboriginal and non-Aboriginal populations in Western Australia
| ||||
Katzenellenbogen (2015) [30] Conference abstract later published as a journal article (this study has multiple outcomes) | Country: Australia (Western Australia only) | Design: baseline data of retrospective cohort | Aboriginal age-specific rates higher than non-Aboriginal rates in all ages <70 years | NOS (adapted for cross-sectional): 10/10 Coverage of whole State with linked data but admitted hospital cases only; no data on diagnostic tests and medications; diagnostic codes not validated |
Population: Aboriginal | Data Source: Linked hospital and death records | ASRR: 20–54 years = 3.6 (males) and 6.4 (females) 55–84 years = 1.3 (males) and 1.8 (females) | ||
Age: 20–84 years | Setting: Western Australian hospital cases | |||
Period: 2000-09 | Other: 15-year clearance period | |||
Sample size: 37,097 AF cases, 923 Aboriginal | ||||
Prevalence in population | ||||
Title: Cardiovascular Disease Rates, Outcomes, and Quality of Care in Ontario Métis: A Population-Based Cohort Study
| ||||
Atzema (2015) [31] Journal article (this study has multiple outcomes) | Country: Canada (Ontario only) | Design: Retrospective study | Age- & sex-adjusted prevalence per 100 (CI): Métis 2.08 (1.82–2.34) | NOS (adapted for cross-sectional): 8/10Prevalence not well-defined. Register not representative, out-of-hospital cases not included, numerators not provided and likely to be small numbers |
Population: Métis | Data Source: Métis register linked to emergency department (ED), in-patient hospital & mortality records | All Ontario 1.42 (1.41–1.43) | ||
Period: 2006-2011 | Setting: ED and hospital based cases | p < 0.001 | ||
Age: 20 years & over | Sample size: 12,550 (17 % of provincial Métis population) | |||
Title: Racial differences in the prevalence of atrial fibrillation among males
| ||||
Borzecki (2008) [34] Journal article | Country: US | Design: Cross-sectional | Prevalence in male Veterans higher among White than Native Americans Age-adjusted: White 5.7 % Native American 5.4 % Multivariate OR 1.15; 95 % CI 1.04-1.27 (adjusted for age, BMI and predisposing comorbidities) | NOS: (adapted for cross-sectional) 10/10 High quality whole-of-nation study. Survey response only 67 % Whites & 55 % Native Americans, but analyses of administrative data from non-respondents support lower prevalence of AF among Native Americans vs Whites. Restricted to male veterans: military recruiting may limit generalisability |
Population: Native American/Alaskan/Hawaiian | Data Source: administrative database plus health survey | |||
Period: 1997-1999 | Setting: population-based (male veterans) | |||
Age: 18 years & over | Sample size: 664,754 respondents (27,697 Native Americans) | |||
Titles: 1. Heart failure, ventricular dysfunction and risk factor prevalence in Australian Aboriginal peoples: the Heart of the Heart Study
| ||||
2. Cardiometabolic risk and disease in Indigenous Australians: the Heart of the Heart Study
| ||||
Country: Australia | Design: Cross-sectional | Crude prevalence of AF = 2.5 % Similar prevalence <40 and 40–55 years (1 %; n = 3), higher prevalence 56+ years (8 %; n = 8). Similar prevalence between remote and town communities. | NOS (adapted for cross sectional): 8/10 (AF not main outcome) Standardised measurements; out-of-hospital and undiagnosed cases included; small numbers; estimated 10 % enrolled, representativeness unknown, possible selection bias | |
Population: Aboriginal | Data Source: Community survey, including psycho-social, biological and clinical measures | |||
Age: 17+ years | Setting: 3 communities in Central Australia | |||
Period: 2008-09 | Sample size: 436 volunteers | |||
Title: Twelve Lead Electrocardiographic Findings Among Māori and non-Māori at Risk of Cardiovascular Disease in NZ
| ||||
Martin (2013) [37] Conference abstract | Country: NZ | Design: baseline descriptive (within cohort study) | Atrial fibrillation frequencies: 2 % rural Māori 1.2 % urban Māori 0.4 % urban non-Māori | NOS: N/A (abstract) No data provided on age/sex distribution, no statistical inference |
Population: Māori | Data Source: ‘randomly selected’ community samples from the Hauora Manawa Community Heart Study cohort: 12-lead ECG | |||
Age: 20–64 years | Setting: two Māori Communities (rural, urban) and a non-Māori urban cohort | |||
Period: Not known | Sample size: 252 rural Māori, 243 urban Māori, 256 urban non- Māori | |||
Title: The Burden of Atrial Fibrillation in Octogenarians
| ||||
Teh (2013) [38] Conference abstract | Country: NZ | Design: baseline descriptive (within cohort study) | 30 % Māori versus 21 % non-Māori had AF, either on ECG or NZHIS records 7 % Māori versus 4 % non-Māori had AF newly detected by study ECG | NOS: N/A (abstract) No statistical inferential data or eligibility exclusions reported Stroke reported as a comorbidity in 27 % of Māori and 35 % of non-Māori subjects |
Population: Māori | Data Source: Life and Living to Advanced Age (NZ) cohort: 12-lead ECG plus NZHIS | |||
Age: 80-90 | Setting: community | |||
Period: 2010-2011 | Sample size: Overall cohort: 421 Māori aged 80–90; 516 non- Māori all aged 85.615 (66 %) participants had ECG; 870 (93 %) consented to NZHIS record examination | |||
Admission Rates (unlinked) | ||||
Title: The Management of People with Atrial Fibrillation and Flutter: Evidence-based Best Practice Guideline
| ||||
New Zealand Guidelines Group (2005) [39] Report | Country: NZ | Design: Descriptive | Hospital discharges with AF diagnosis: Age-standardised rate for Māori almost twice that of non-Māori (104 per 100,000 vs 57 per 100,000, p < 0.05) Standardised discharge ratio (observed versus expected) 1.945 for Māori & 0.972 for ‘others’ (where 1.0 is the national average) Modal age group: Māori 65–69 years, ‘other’ males 75–79 years, ‘other’ females >85 years | NOS: N/A (report with insufficient methodological detail published) Unlinked administrative data |
Population: Māori | Data Source: National minimum dataset | |||
Period: 2001-2002 | Setting: Hospital patients | |||
Age: unrestricted | Sample size: (whole of NZ data; sample size not stated) |
Population-based epidemiological indices of AF
Incidence
Prevalence
Life-time risk
Hospital admission rates
Outcomes in AF patients
Author (Year) Publication type | Country Indigenous population Calendar period Age range | Methods | Key findings on Indigenous AF | Quality score (Newcastle-Ottawa Scale applied only to Indigenous AF data) Comments |
---|---|---|---|---|
Outcomes in AF patients | ||||
Title: Cardiovascular Disease Rates, Outcomes, and Quality of Care in Ontario Métis: A Population-Based Cohort Study
| ||||
Atzema (2015) [31] Journal article (this study has multiple outcomes) | Country: Canada (Ontario only) | Design: Retrospective cohort study | Age- & sex-adjusted all cause mortality (CI) Métis 16.6 (7.3–25.4) All Ontario 7.8 (7.5–8.1) p = 0.06 | NOS (cohort): 7/9 ‘Incidence case’ denominator determined by first emergency department presentation or hospitalisation onlySmall number of Métis subjects |
Population: Métis | Outcomes: One-year all-cause and cardiovascular mortality in incident cases () | Age- & sex-adjusted cardiovascular mortality (CI) Métis 10.0 (2.4–17.7) | ||
Period: 2006-2011 | Sample size: 6 deaths in 56 Métis; 32,387 general Ontarian incident cases | All Ontario 4.8 (4.6–5.0) p = 0.19 | ||
Age: 20+ years | ||||
Title: African Americans have the highest risk of in-hospital mortality with atrial fibrillation related hospitalizations among all racial/ethnic groups: A nationwide analysis
| ||||
Turagam (2012) [41] Journal research letter | Country: US | Design: cross-sectional/cohort | In-hospital mortality following admission with AF as principal diagnosis: Native Americans vs Whites adjusted HR 0.7 (p = 0.3) | NOS (adapted for cross sectional) 8/10 Unlinked data; short follow-up (hospital deaths only) |
Population: Native American | Data Source: Nationwide Inpatient Sample hospitalization database | |||
Period: 2008 | Setting: hospitals | |||
Age: uncertain | Sample size: 425470 admitted with AF as principal diagnosis | |||
Title: Initial hospitalisation for atrial fibrillation in Aboriginal and non-Aboriginal populations in Western Australia
| ||||
Katzenellenbogen (2015) [30] Conference abstract later published as a journal article (this study has multiple outcomes) | Country: Australia (Western Australia only) | Design: Retrospective cohort | 1-year mortality: cross-over effect 30-day mortality: Demography-adjusted HR = 1.7 | NOS (cohort): 9/9 Hospitalised cases only AF codes not validated No diagnostic tests and therapeutic data |
Population: Aboriginal | Data Source: Linked hospital and death records | Fully adjusted HR = 0.81 (NS) 1-yr mortality in 30-day survivors: Demography-adjusted HR = 2.9 | ||
Age: 20–84 years | Setting: Western Australian hospital cases | Fully adjusted HR = 1.6 Comorbidities impact substantially on attenuation of effect | ||
Period: 2000-09 | Other: 15-year clearance period | |||
Sample size: 37,097 AF cases, 923 Aboriginal; 5,417 mortality events | ||||
AF as an outcome | ||||
Title: Race/ethnicity and the incidence of new-onset atrial fibrillation after isolated coronary artery bypass surgery
| ||||
Nazeri (2010) [42] Journal article | Country: US | Design: retrospective cohort | Cumulative incidence prior to discharge of new-onset post-operative AF (crude percentages; no statistical inference) Caucasians: 32.4 % Native Americans: 18.8 % | NOS (cohort) 7/9 Descriptive study only in relation to Native Americans Very small number of Native Americans insufficient for multivariate analysis |
Pop: Native Americans | Data Source: Institutional research database | |||
Period: 2000-2008 | Setting: Single tertiary hospital | |||
Sample size: Total: 5823 | ||||
Native American: 11 (0.2 %) |
AF as a complication
AF in clinical groups
Author (Year) Publication type | Country Indigenous population Calendar period | Methods | Key findings on Indigenous AF | Quality score (Newcastle-Ottawa Scale applied only to Indigenous AF data) Comments |
---|---|---|---|---|
(a) Frequency of atrial fibrillation in primary care consultations | ||||
Title: Aboriginal and Torres Strait Islander Health Performance Framework 2012 - Detailed Analyses
| ||||
Australian Institute of Health and Welfare (2013) [40] Report | Country: Australia | Design: Cross-sectional | Age-standardised rate (no. of encounters per 1,000 in which AF managed): Indigenous: 15.1 (CI 5.7-24.4) Other: 11.5 (CI 11.0-12.0) Rate ratio 1.3 (NS) Rate difference 3.5 (NS) | NOS (adapted for cross-sectional): 5/10 |
Pop: Aboriginal | Data Source: BEACH (written questionnaire, random sample of GPs across Australia) | Likely under-identification of Indigenous patients | ||
Period: 2006–07 to 2011-12 | Setting: General practice attendances | |||
Sample size: AF managed during 38 ‘Indigenous’ and 5548 ‘Other’ GP attendances | ||||
(b) Frequency of atrial fibrillation in hospital admissions | ||||
Title: Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study
| ||||
Wong (2014) [29] Conference abstract later published as a journal article | Country: Australia | Design: Retrospective cross-sectional study | Indigenous vs non-Indigenous frequency of AF adjusted for age, sex & CVD comorbidity (odds ratio): 1.183 (CI 0.977-1.432; p = 0.085) | NOS (adapted for cross-sectional): 5/10 Unclear definition of AF occurrence (throughout series of ≥1 potential admission per patient) No ‘lookback’ to establish age at 1st AF admission Representativeness of population uncertain from single institution Denominator for comparisons unclear |
Pop: Indigenous Australians (IA) | Data Source: Administrative data | Crude age-stratified frequency of AF Indigenous vs non-Indigenous: <60 yrs 2.57 vs 1.73 % p < 0.0001 ≥ 60 yrs 4.61 vs 9.26 % p < 0.0001 | ||
Period: 2000-2009 | Setting: Single tertiary hospital (South Australia) | Average age of patients with AF (years): Indigenous 55.4 (SD 13.2) vs Non-Indigenous 74.5 (SD 13.1) p < 0.001 | ||
Sample size: 204668 persons admitted (5892 Indigenous [3.6 %]) 14373 patients with AF diagnosis (221 Indigenous) | ||||
(c) Frequency of atrial fibrillation in specific diagnostic groups | ||||
i. Heart failure | ||||
Title: Incidence of first heart failure hospitalisation and mortality in Aboriginal and non-Aboriginal patients in Western Australia, 2000-2009
| ||||
Teng (2014) [44] Journal article | Country: Australia | Design: baseline descriptive (within cohort study) hospitalised HF patients | Crude AF prevalence significantly higher in non-Aboriginal patients: 20–55 years | NOS (adapted for cross-sectional): 9/10 15-year clearance period to identify first HF admission; codes validated; 5-year look back for history of AF |
Pop: Aboriginal | Data Source: Linked hospital and death records | Aboriginal = 17.2 % Non-Aboriginal = 26.6 % p < 0.001 55–84 years | ||
Period: 2000-2009 | Setting: Hospital | Aboriginal = 24.6 %% Non-Aboriginal = 44.9 % p < 0.001 | ||
Sample size: 1013 Aboriginal and 16,366 non-Aboriginal hospitalised HF patients | ||||
Title: Mortality outcomes among status Aboriginals and Whites with Heart Failure
| ||||
Lyons (2014) [43] Journal article | Country: Alberta, Canada | Design: baseline descriptive (within cohort study) | Crude prevalence of AF (as comorbidity): Aboriginals (18 %); Whites (34 %) | NOS (adapted for cross-sectional): 8/10 Albertan Aboriginal population comprises 52 % First Nations, 45 % Métis & 3 % Inuit. Identification of Indigenous status in study based on registration—only First Nations are eligible, of whom 81 % are registered. Métis classified as White in this study. |
Pop: Aboriginal | Data Source: Health care administrative (HMD, ED, ambulatory care) databases linked to the insurance registry (with ethnicity recorded) | |||
Period: 2000-2008 | Setting: Hospital | |||
Sample size: 42,288 whites, 1158 Aboriginals | ||||
ii. Ischaemic heart disease | ||||
Title: Ischaemic heart disease in New Zealand Māori and non-Māori: an age adjusted incidence in hospitalised patients over 10 years with emphasis on clinical features in the Māori
| ||||
Dancaster (1982) [45] Journal article | Country: NZ | Design: Descriptive | AF detected in 39 % of Māori versus 6 % of non-Māori cases | NOS (adapted for cross-sectional): 3/10 No statistical inference data given for AF proportions Old study—contemporary relevance uncertain |
Pop: Māori | Data Source: Hospital records | |||
Period: 1971-1980 | Setting: Single regional hospital CCU | |||
Sample size: 887 CCU-admitted IHD cases | ||||
iii. Renal failure | ||||
Title: Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?
| ||||
To (2007) [48] Journal article | Country: NZ | Design: baseline descriptive (within cohort study) Data Source: Subjects identified from identified from ANZ Dialysis and Transplant Registry; Hospital records—30 month follow-up | Crude percentage AF: Caucasians 32.8 % Māori 28.6 % Pacific Islanders 19.6 % Asians 16.7 % | NOS (adapted for cross-sectional): 6/10 Underpowered, therefore essentially descriptive study of AF prevalence |
Pop: Māori | Setting: Single hospital haemodialysis unit | |||
Period: 2003 | Sample size: 155 haemodialysis patients; 28 (18 %) Māori, 51 (33 %) Pacific Islander | |||
Title: Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States
| ||||
Goldstein (2012) [47] Journal article | Country: US | Design: Cohort study | Crude incidence rate: 148/1000 person-years Compared to non-Hispanic whites, Blacks (−30 %), Asians (−29 %) & Native Americans have lower risk (−42 %) of incident AFCrude incidence rate: 148/1000 person-years Compared to non-Hispanic whites, Blacks (−30 %), Asians (−29 %) & Native Americans have lower risk (−42 %) of incident AF | NOS (cohort): 9/9 Small sample size for Native Americans (1 %). |
Pop: Native Americans | Data Source: US Renal Data System | |||
Period: 1995-2007 | Setting: Population-based (older Medicare beneficiaries) | |||
Sample size: 258,605 (1 % Native Americans) | ||||
Title: The increasing prevalence of atrial fibrillation among hemodialysis patients
| ||||
Winkelmayer (2011) [46] Journal article | Country: US | Design: series of cross-sectional surveys | Native American HD patients univariate RR for AF 0.38 (vs Causasian); adjusted RR 0.53 (CI 0.50-0.57) | NOS (adapted for cross-sectional): 10/10 |
Pop: Native American | Data Source: United States Renal Data System | |||
Period: 1992-2006 | Setting: maintenance hemodialysis pts—whole of USA | |||
Sample size: >105 pts each year of study | ||||
iv. Stroke | ||||
Title: Prevalence of stroke and coexistent conditions: disparities between Indigenous and non-Indigenous Western Australians
| ||||
Katzenellenbogen (2014) [49] Journal article | Country: Australia | Design: baseline descriptive (within cohort study) | AF more prevalent in Aboriginal than other stroke cases in all age groups <70 years. Crude AF rates were 20 % less in Aboriginal patients due to differing age distributions. | NOS (adapted for cross-sectional): 7/10 (AF not focus of study) Long (20-year) look-back period to identify stroke and AF; AF codes not validated; no stroke type data |
Pop: Aboriginal | Data Source: Linked hospital and death records | |||
Period: 2007-2011 | Setting: Hospital | |||
Sample size: Average 13,591 patients per year (5 % Aboriginal) | ||||
Title: Racial disparities among Native Hawaiians and Pacific Islanders with intracerebral hemorrhage
| ||||
Nakagawa (2012) [50] Journal article | Country: Hawaii, US | Design: Cross-sectional | Crude prevalence of AF: No significant difference between whites & NHPI (10 % vs 17 %) | NOS (adapted for cross-sectional): 7/10 |
Pop: Native Hawaiians & Pacific Islander (NHPI) | Data Source: Clinical database | Single-centre (referral bias). Good clinical data. Limited analysis, given small sample size | ||
Period: 2004-2010 | Setting: Hospital admissions from single tertiary hospital | |||
Sample size: 562 ICH cases | ||||
Title: Disparities among Asians and native Hawaiians and Pacific Islanders with ischemic stroke
| ||||
Nakagawa (2013) [51] Journal article | Country: Hawaii, USA | Design: Cross-sectional | AF prevalence: No significant difference between whites & NHPI Crude prevalence 15 % vs 19 % Adjusted OR 1.06 (0.64-1.75) | NOS (adapted for cross-sectional): 8/10 Single-centre (referral bias). Good clinical data. |
Pop: NHPI | Data Source: Clinical database | |||
Period: 2004-2010 | Setting: Hospital admissions from single tertiary hospital | |||
Sample size: 1,921 ischaemic strokes | ||||
v. Rheumatic heart disease | ||||
Title: Percutaneous balloon mitral commissurotomy in Indigenous versus non-Indigenous Australians | ||||
McCann (2008) [52] Journal article | Country: Australia | Design: baseline descriptive (within cohort study) | Crude AF prevalence: non-significantly lower in Indigenous Australians (44 % vs 29 %) | NOS (adapted for cross-sectional): 7/10 Only 36 (11 %) of Indigenous Australians. Age-adjusted survival was worse in Indigenous Australians. |
Pop: Indigenous Australians | Data Source: Clinical database | |||
Period: 1990-2006 | Setting: two tertiary hospitals | |||
Sample size: 327 | ||||
Title: A review of valve surgery for rheumatic heart disease in Australia
| ||||
Russell (2014) [53] Journal article | Country: Australia | Design: Cross-sectional | Crude frequency of perioperative AF (%): Indigenous 33.3 Non-Indigenous 41.6 (p = 0.039) n.b., difference in mean age: Indigenous 37.4 years Non-Indigenous 65.1 year | NOS: N/A (descriptive study) Comparison of crude frequencies of AF in the two ethnic categories is markedly confounded by age disparity |
Pop: Aboriginal & Torres Strait Islander | Data Source: National Cardiac Surgery Database | |||
Period: 2001-2012 | Setting: Hospitalised surgery patients | |||
Sample size: 1384 RHD (174 Indigenous) compared with 15843 non-RHD valvular surgery patients | ||||
vi. Other cardiac surgery | ||||
Title: Incidence, secular trends, and outcomes of cardiac surgery in Aboriginal peoples
| ||||
Sood (2013) [54] Journal article | Country: Canada | Design: baseline descriptive (within cohort study) | No significant difference in AF prevalence at baseline (10.1 % non-Aboriginal v 12.0 % Aboriginal) | NOS (cohort): 9/9 Main aims were to compare Aboriginal vs non-Aboriginal patients for incidence, secular trends & outcomes of cardiac surgery. Limited info on AF: crude baseline prevalence in a cohort with known selection bias (demonstrated disparity in selection for surgery) |
Pop: Canadian Aboriginal | Data Source: Provincial Cardiac Surgery registry | |||
Period: 1995-2007 | Setting: Whole of Manitoba | |||
Age: >15 years | Sample size: 12170 (Aboriginal 574; 4.7 %) | |||
vii. Paediatric patients | ||||
Title: Excellent cardiac surgical outcomes in paediatric indigenous patients, but follow-up difficulties
| ||||
Rohde (2010) [55] Journal article | Country: Brisbane, AUS | Design: Retrospective review | New atrial arrhythmia as post-surgical complication: 2.4 % | NOS (adapted for cross-sectional): 7/10 Atrial arrhythymia was one endpoint (complication) of follow-up after cardiac surgery. |
Pop: Indigenous Australians (paediatric) | Data Source: Cardiothoracic database, chart review | |||
Period: 2002-2009 | Setting: Single tertiary hospital | |||
Sample size: 112 cases (123 operations) | ||||
Title: Preoperative risk factors for long-term survival following cardiac surgery for rheumatic heart disease in the young
| ||||
Remenyi (2012) [56] Conference abstract | Country: Auckland, NZ | Design: Retrospective cohort study | Pre-operative AF independently predicted mortality in multivariate analysis (HR 5.2, p < 0.01) | NOS: N/A (abstract) No Causasian comparison group |
Pop: Māori & PI | Data Source: Cardiothoracic database, chart review | |||
Period: 1990-2006 | Setting: Single tertiary hospital | |||
Sample size: 212 cases |